Neumora Therapeutics Inc....
(NMRA)
undefined
undefined%
At close: undefined
10.32
0.29%
After-hours Dec 13, 2024, 04:39 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 374.04M | 240.94M | 409.25M | 191.98M | - |
| Short-Term Investments | 79.94M | 130.94M | - | - | - |
| Long-Term Investments | 9.85M | 23.51M | - | - | - |
| Other Long-Term Assets | 1.21M | 4.13M | 9.65M | 183.00K | - |
| Receivables | 939.00K | 919.00K | 200.00K | 148.00K | - |
| Inventory | - | 50.00K | 125.00K | - | - |
| Other Current Assets | 23.36M | 15.15M | 6.16M | 1.72M | - |
| Total Current Assets | 478.28M | 387.95M | 415.60M | 193.84M | - |
| Property-Plant & Equipment | 6.86M | 10.64M | 4.04M | 3.92M | - |
| Goodwill & Intangibles | - | - | - | - | - |
| Total Long-Term Assets | 17.92M | 38.28M | 13.69M | 4.11M | - |
| Total Assets | 496.19M | 426.23M | 429.30M | 197.95M | - |
| Account Payables | 337.00K | 7.15M | 1.64M | 2.40M | - |
| Deferred Revenue | - | 11.54M | 19.10M | 5.60M | - |
| Short-Term Debt | 6.76M | 3.37M | 1.06M | 764.00K | - |
| Other Current Liabilities | 18.02M | 13.18M | 20.58M | 6.21M | 21.00K |
| Total Current Liabilities | 25.11M | 23.70M | 23.28M | 9.37M | 21.00K |
| Long-Term Debt | 1.85M | 5.07M | 996.00K | 1.28M | - |
| Other Long-Term Liabilities | 155.00K | 844.32M | 730.24M | 281.68M | - |
| Total Long-Term Liabilities | 2.01M | 849.39M | 731.24M | 282.96M | - |
| Total Liabilities | 27.12M | 873.08M | 754.52M | 292.33M | 21.00K |
| Total Debt | 5.23M | 8.44M | 2.05M | 2.04M | - |
| Common Stock | 16.00K | 16.00K | 14.00K | 13.00K | - |
| Retained Earnings | -703.43M | -467.51M | -336.61M | -99.29M | -21.00K |
| Comprehensive Income | -76.00K | -774.00K | -729.86M | - | - |
| Shareholders Equity | 469.08M | -446.85M | -325.22M | -94.38M | -21.00K |
| Total Investments | 89.79M | 154.45M | - | - | - |